[go: up one dir, main page]

DE69811018D1 - Triazol-Derivate und ihre Verwendung als antimykotische Mittel - Google Patents

Triazol-Derivate und ihre Verwendung als antimykotische Mittel

Info

Publication number
DE69811018D1
DE69811018D1 DE69811018T DE69811018T DE69811018D1 DE 69811018 D1 DE69811018 D1 DE 69811018D1 DE 69811018 T DE69811018 T DE 69811018T DE 69811018 T DE69811018 T DE 69811018T DE 69811018 D1 DE69811018 D1 DE 69811018D1
Authority
DE
Germany
Prior art keywords
antifungal agents
triazole derivatives
triazole
derivatives
antifungal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69811018T
Other languages
English (en)
Other versions
DE69811018T2 (de
Inventor
Yasushi Kaneko
Sunao Takeda
Minoru Tokizawa
Hiromichi Eto
Kazuya Ishida
Kazunori Maebashi
Masaru Matsumoto
Takemitsu Asaoka
Susumu Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of DE69811018D1 publication Critical patent/DE69811018D1/de
Application granted granted Critical
Publication of DE69811018T2 publication Critical patent/DE69811018T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69811018T 1997-08-29 1998-08-19 Triazol-Derivate und ihre Verwendung als antimykotische Mittel Expired - Fee Related DE69811018T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23454697 1997-08-29

Publications (2)

Publication Number Publication Date
DE69811018D1 true DE69811018D1 (de) 2003-03-06
DE69811018T2 DE69811018T2 (de) 2003-10-02

Family

ID=16972725

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811018T Expired - Fee Related DE69811018T2 (de) 1997-08-29 1998-08-19 Triazol-Derivate und ihre Verwendung als antimykotische Mittel

Country Status (7)

Country Link
US (1) US6008239A (de)
EP (1) EP0899265B1 (de)
KR (1) KR19990023952A (de)
CN (1) CN1210857A (de)
CA (1) CA2246125A1 (de)
DE (1) DE69811018T2 (de)
TW (1) TW438784B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3638438B2 (ja) 1997-12-26 2005-04-13 エスエス製薬株式会社 トリアゾール誘導体またはその塩、その製造方法及び当該化合物を有効成分とする医薬
EP0933368A1 (de) 1998-02-02 1999-08-04 SSP Co., Ltd. Triazol-derivate oder deren Salze mit antimykotischer Wirkung, Herstellungsverfahren und pharmazeutische Zusammensetzung diese enthaltend
JP2000226368A (ja) 1999-02-04 2000-08-15 Ss Pharmaceut Co Ltd ジフルオロアセトフェノン誘導体の製造法
KR20010050557A (ko) 1999-09-29 2001-06-15 타이도 나오카타 아졸 유도체 또는 그의 염
KR100686537B1 (ko) * 2001-12-28 2007-02-27 씨제이 주식회사 사이클로옥시게나제-2 의 저해제로서 선택성이 뛰어난디아릴 1,2,4-트리아졸 유도체
KR100467668B1 (ko) * 2002-08-07 2005-01-24 씨제이 주식회사 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
EP1388352A1 (de) 2002-08-08 2004-02-11 Laboratoires Fournier S.A. Verwendung eines ppar-alpha-Agonisten zur Behandlung von Patienten, die an mit ppar-gamma-Agonisten-Behandlung assozierter Fettleibigkeit leiden
EP1457206A1 (de) * 2003-03-13 2004-09-15 Fournier Laboratories Ireland Limited Kombinierte Verwendung von einem Fibrat und von Orlistat zur Behandlung von Obesitas
EP1621200A1 (de) * 2004-07-26 2006-02-01 Fournier Laboratories Ireland Limited Pharmazeutische Kombinationen enthaltend einen Hemmstoff der Plättchenaggregation und ein Fibrat
CN1874658B (zh) * 2005-06-03 2011-09-21 深圳富泰宏精密工业有限公司 携带式电子装置电池盖结构
AR065670A1 (es) 2007-03-09 2009-06-24 Indigene Pharmaceuticals Inc Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas
WO2013169648A1 (en) 2012-05-07 2013-11-14 Novartis Ag Pharmaceutical combinations comprising a dgat1 inhibtor and a triglyceride lowering drug

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG48681A3 (en) * 1982-12-14 1991-04-15 Ciba - Geigy Ag Fungicide means
DE3461637D1 (en) * 1983-02-16 1987-01-22 Pfizer Ltd Triazole antifungal agents
NO913302L (no) * 1990-08-26 1992-03-02 Sankyo Co Anti-fungale triazolderivater, samt fremstilling og anvendelse derav
JPH06247944A (ja) * 1992-12-28 1994-09-06 Sumitomo Pharmaceut Co Ltd 新規な１，２，４−トリアゾール誘導体
EP0780380B1 (de) * 1995-12-22 2001-06-13 Ss Pharmaceutical Co., Ltd. Triazol-Derivate mit antimykotischer Wirkung und Zwischenprodukte
US5939448A (en) * 1996-06-21 1999-08-17 Ss Pharmaceutical Co., Ltd. Triazole derivative or salt thereof

Also Published As

Publication number Publication date
KR19990023952A (ko) 1999-03-25
CN1210857A (zh) 1999-03-17
TW438784B (en) 2001-06-07
US6008239A (en) 1999-12-28
CA2246125A1 (en) 1999-02-28
DE69811018T2 (de) 2003-10-02
EP0899265B1 (de) 2003-01-29
EP0899265A1 (de) 1999-03-03

Similar Documents

Publication Publication Date Title
DE59710422D1 (de) Acylmercapto-triazolyl-derivate und ihre verwendung als mikrobizide
DE59710580D1 (de) Thiocyano-triazolyl-derivate und ihre verwendung als mikrobizide
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
DE59712887D1 (de) Substituierte phenylketoenole und ihre verwendung als schädlingsbekämpfungsmittel
DE122007000020I2 (de) Substituierte 3,5-diphenyl-1,2,4-triazole und ihre verwendung als pharmazeutische metallchelatoren
ATE216370T1 (de) Pyrimidin-4-on und pyrmidin-4-thion als fungicide
DE59710423D1 (de) Triazolyl-mercaptide und ihre verwendung als mikrobizide
DE69929983D1 (de) Trifluoromethylpyrrolcarboxamide und ihre anwendung als fungizide
DE69720194D1 (de) Piperazinonphenyloxazolidinon derivate und ihre verwendung als antibakterielle mittel
DE59803292D1 (de) Triazolverbindungen und deren verwendung als dopamin-d 3-liganden
DE59813869D1 (de) 4-(3-heterocyclyl-1-benzoyl)pyrazole und ihre verwendung als herbizide
ATE310739T1 (de) Pyrazol-4-yl-benzoylderivate und ihre verwendung als herbizide
DE69618959D1 (de) Pyrimidone und ihre verwendug als fungizide
DE59710579D1 (de) Sulfonyl-mercapto-triazolyl-derivate und ihre verwendung als mikrobizide
DE69818248D1 (de) Chinolin- und chinazolin-derivate als crf antagonisten
DE69826693D1 (de) Amidinoderivate und ihre verwendung als thrombininhibitoren
DE69811018D1 (de) Triazol-Derivate und ihre Verwendung als antimykotische Mittel
DE69902387D1 (de) Oxadiazolinderivate und ihre verwendung als insektizide
DE69613805D1 (de) Diiminoquinonderivate und ihre Verwendung als Elektronübertragungsmittel
DE69510228D1 (de) Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
DE69719658D1 (de) Dihyropyridazinon- und pyridazinonderivate und ihre verwendung als insektizide und fungizide
DE69832902D1 (de) Oromukosal-zytokin-zusammensetzungen und ihre verwendung
DE69821988D1 (de) Substituierte isochinoline derivate und ihre verwendung als anticonvulsiva
DE69631249D1 (de) Triazoline und isoxazoline bis-oxime -derivate und ihre verwendung als pestizide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee